Alamar Biosciences, Inc. Common Stock vs. Bio-Rad Laboratories, Inc.Class A
ALMR
Alamar Biosciences, Inc. Common Stock
$32.14 -3.25%
VS BIOBio-Rad Laboratories, Inc.Class A
$378.88 -0.18%
Alamar Biosciences, Inc. Common Stock and Bio-Rad Laboratories, Inc.Class A are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ALMR | BIO | |
|---|---|---|
| Market Cap | $2.31 billion | $10.15 billion |
| Revenue (TTM) | — | $2.59 billion |
| Net Income (TTM) | — | $222.40 million |
BIO leads on 1 of 1 size & scale factors.
Valuation
| ALMR | BIO | |
|---|---|---|
| P/E Ratio | — | 46.15 |
| Price / Book | — | 1.41 |
| Price / Sales | — | 3.92 |
ALMR and BIO split the valuation factors evenly.
Profitability
| ALMR | BIO | |
|---|---|---|
| Net Margin | — | 8.59% |
| Return on Equity | — | 3.10% |
ALMR and BIO split the profitability factors evenly.
Risk & Sentiment
| ALMR | BIO | |
|---|---|---|
| Short Interest | 1.66% | 2.44% |
ALMR leads on 1 of 1 risk & sentiment factors.
Dig deeper: ALMR overview, ALMR financials, BIO overview, BIO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.